Literature DB >> 28270694

Acinar cell plasticity and development of pancreatic ductal adenocarcinoma.

Peter Storz1.   

Abstract

Acinar cells in the adult pancreas show high plasticity and can undergo transdifferentiation to a progenitor-like cell type with ductal characteristics. This process, termed acinar-to-ductal metaplasia (ADM), is an important feature facilitating pancreas regeneration after injury. Data from animal models show that cells that undergo ADM in response to oncogenic signalling are precursors for pancreatic intraepithelial neoplasia lesions, which can further progress to pancreatic ductal adenocarcinoma (PDAC). As human pancreatic adenocarcinoma is often diagnosed at a stage of metastatic disease, understanding the processes that lead to its initiation is important for the discovery of markers for early detection, as well as options that enable an early intervention. Here, the critical determinants of acinar cell plasticity are discussed, in addition to the intracellular and extracellular signalling events that drive acinar cell metaplasia and their contribution to development of PDAC.

Entities:  

Mesh:

Year:  2017        PMID: 28270694      PMCID: PMC6036907          DOI: 10.1038/nrgastro.2017.12

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  119 in total

1.  Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation.

Authors:  Takeshi Miyatsuka; Hideaki Kaneto; Toshihiko Shiraiwa; Taka-aki Matsuoka; Kaoru Yamamoto; Ken Kato; Yumiko Nakamura; Shizuo Akira; Kiyoshi Takeda; Yoshitaka Kajimoto; Yoshimitsu Yamasaki; Eric P Sandgren; Yoshiya Kawaguchi; Christopher V E Wright; Yoshio Fujitani
Journal:  Genes Dev       Date:  2006-06-01       Impact factor: 11.361

2.  Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.

Authors:  Michaela Aichler; Christopher Seiler; Monica Tost; Jens Siveke; Pawel K Mazur; Patricia Da Silva-Buttkus; Detlef K Bartsch; Peter Langer; Sara Chiblak; Anna Dürr; Heinz Höfler; Günter Klöppel; Karin Müller-Decker; Markus Brielmeier; Irene Esposito
Journal:  J Pathol       Date:  2012-01-17       Impact factor: 7.996

3.  Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment.

Authors:  Irene Esposito; Christopher Seiler; Frank Bergmann; Jörg Kleeff; Helmut Friess; Peter Schirmacher
Journal:  Pancreas       Date:  2007-10       Impact factor: 3.327

4.  Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma.

Authors:  Janel L Kopp; Guido von Figura; Erin Mayes; Fen-Fen Liu; Claire L Dubois; John P Morris; Fong Cheng Pan; Haruhiko Akiyama; Christopher V E Wright; Kristin Jensen; Matthias Hebrok; Maike Sander
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

Review 5.  Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer.

Authors:  Craig D Logsdon; Baoan Ji
Journal:  Clin Gastroenterol Hepatol       Date:  2009-11       Impact factor: 11.382

6.  Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells.

Authors:  Dongfeng Qu; Jeremy Johnson; Parthasarathy Chandrakesan; Nathaniel Weygant; Randal May; Nicole Aiello; Andrew Rhim; Lichao Zhao; Wei Zheng; Stanley Lightfoot; Shubham Pant; Jeremy Irvan; Russell Postier; James Hocker; Jay S Hanas; Naushad Ali; Sripathi M Sureban; Guangyu An; Michael J Schlosser; Ben Stanger; Courtney W Houchen
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

7.  Protein kinase D1 drives pancreatic acinar cell reprogramming and progression to intraepithelial neoplasia.

Authors:  Geou-Yarh Liou; Heike Döppler; Ursula B Braun; Richard Panayiotou; Michele Scotti Buzhardt; Derek C Radisky; Howard C Crawford; Alan P Fields; Nicole R Murray; Q Jane Wang; Michael Leitges; Peter Storz
Journal:  Nat Commun       Date:  2015-02-20       Impact factor: 14.919

8.  Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-κB and MMPs.

Authors:  Geou-Yarh Liou; Heike Döppler; Brian Necela; Murli Krishna; Howard C Crawford; Massimo Raimondo; Peter Storz
Journal:  J Cell Biol       Date:  2013-08-05       Impact factor: 10.539

9.  PD2/Paf1 depletion in pancreatic acinar cells promotes acinar-to-ductal metaplasia.

Authors:  Parama Dey; Satyanarayana Rachagani; Arokia P Vaz; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Oncotarget       Date:  2014-06-30

Review 10.  Fibroblast heterogeneity in the cancer wound.

Authors:  Daniel Öhlund; Ela Elyada; David Tuveson
Journal:  J Exp Med       Date:  2014-07-28       Impact factor: 14.307

View more
  81 in total

Review 1.  Chronic Pancreatitis and the Development of Pancreatic Cancer.

Authors:  Hemanth K Kandikattu; Sathisha U Venkateshaiah; Anil Mishra
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2020       Impact factor: 2.895

Review 2.  Protein kinase C isoforms in the normal pancreas and in pancreatic disease.

Authors:  Alicia K Fleming; Peter Storz
Journal:  Cell Signal       Date:  2017-08-18       Impact factor: 4.315

3.  Novel therapeutic approaches for pancreatic cancer by combined targeting of RAF→MEK→ERK signaling and autophagy survival response.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  Ann Transl Med       Date:  2019-07

4.  Regenerative proliferation of differentiated cells by mTORC1-dependent paligenosis.

Authors:  Spencer G Willet; Mark A Lewis; Zhi-Feng Miao; Dengqun Liu; Megan D Radyk; Rebecca L Cunningham; Joseph Burclaff; Greg Sibbel; Hei-Yong G Lo; Valerie Blanc; Nicholas O Davidson; Zhen-Ning Wang; Jason C Mills
Journal:  EMBO J       Date:  2018-02-21       Impact factor: 11.598

5.  Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma.

Authors:  Nilay Sethi; Osamu Kikuchi; James McFarland; Yanxi Zhang; Max Chung; Nicholas Kafker; Mirazul Islam; Benjamin Lampson; Abhishek Chakraborty; William G Kaelin; Adam J Bass
Journal:  JCI Insight       Date:  2019-08-08

6.  Enhancing African American Participation in Biospecimens: A Case in Point for Pancreatic Cancer.

Authors:  Linda Behar-Horenstein; Rueben C Warren; V Wendy Setiawan; Corey Perkins; Thomas D Schmittgen
Journal:  Cancer Health Disparities       Date:  2020-12

7.  KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.

Authors:  Faraz Bishehsari; Lijuan Zhang; Usman Barlass; Nailliw Z Preite; Sanja Turturro; Matthew S Najor; Brandon B Shetuni; Janet P Zayas; Mahboobeh Mahdavinia; Abde M Abukhdeir; Ali Keshavarzian
Journal:  Int J Cancer       Date:  2018-08-09       Impact factor: 7.396

Review 8.  Metabolism and epigenetics of pancreatic cancer stem cells.

Authors:  M Perusina Lanfranca; J K Thompson; F Bednar; C Halbrook; C Lyssiotis; B Levi; T L Frankel
Journal:  Semin Cancer Biol       Date:  2018-09-28       Impact factor: 15.707

9.  Aldh1b1 expression defines progenitor cells in the adult pancreas and is required for Kras-induced pancreatic cancer.

Authors:  Ekaterina Mameishvili; Ioannis Serafimidis; Sara Iwaszkiewicz; Mathias Lesche; Susanne Reinhardt; Nora Bölicke; Maren Büttner; Dimitris Stellas; Adriana Papadimitropoulou; Matthias Szabolcs; Konstantinos Anastassiadis; Andreas Dahl; Fabian Theis; Argiris Efstratiadis; Anthony Gavalas
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

Review 10.  Carcinogenesis of Pancreatic Ductal Adenocarcinoma.

Authors:  Peter Storz; Howard C Crawford
Journal:  Gastroenterology       Date:  2020-03-19       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.